What Happens When You Take Too Much Hydroxyzine?

Taking too much hydroxyzine triggers a cascade of effects across the brain, heart, and autonomic nervous system. In overdose, the drug’s normally mild sedative and antihistamine properties become dangerous: reported symptoms of toxicity include delirium, seizures, rapid heart rate, and low blood pressure, and in severe cases the drug has been linked to life-threatening respiratory failure and circulatory collapse.¹ The good news is that fatal outcomes are rare, but “rare” does not mean “harmless,” and the specific risks depend on how much was taken, what else is in your system, and your age.

How Hydroxyzine Works, and Why Too Much Is a Problem

Hydroxyzine is a first-generation antihistamine prescribed for itching, anxiety, and sometimes insomnia. At normal doses, it blocks histamine receptors in the body, which is what stops allergic itch and causes drowsiness. But it does not stop there. Hydroxyzine also binds to muscarinic, serotonin, and dopamine receptors, giving it a broader pharmacological footprint than many people realize.¹ At therapeutic doses, these extra receptor interactions are generally minor. In overdose, they become the main source of trouble.

The muscarinic receptor blockade, in particular, produces what clinicians call an anticholinergic syndrome. Your body relies on acetylcholine signaling to regulate sweating, saliva production, gut motility, pupil size, and aspects of heart rate. When hydroxyzine floods these receptors, the system goes haywire: skin becomes hot and dry, pupils dilate, the gut slows or stops, and the heart races. The brain effects layer on top of this, ranging from agitation and confusion to hallucinations and seizures.

What an Overdose Actually Looks Like

The severity of symptoms depends heavily on dose. A person who accidentally takes an extra pill or two will likely experience exaggerated drowsiness, dry mouth, and a faster-than-normal heartbeat. These effects are unpleasant but generally self-limiting. The picture changes with large intentional overdoses, where multi-organ involvement becomes a genuine concern.

A large cohort analysis of over 17,000 hydroxyzine poisoning cases reported to the U.S. National Poison Data System found that mild central nervous system depression, essentially heavy sedation, was the most common outcome.² More severe outcomes like deep coma, respiratory failure, and seizures were documented but occurred at lower rates. In case reports of very large ingestions, the picture has been much worse: one patient developed severe acute respiratory distress syndrome (where the lungs fill with fluid) alongside a dangerous drop in blood pressure, requiring mechanical ventilation.¹

The typical progression in a serious overdose looks something like this:

Early (1–3 hours): Drowsiness, dry mouth, blurred vision, flushing, mild confusion, rapid heartbeat.
Moderate toxicity: Agitation or delirium, visual hallucinations, fever from inability to sweat, urinary retention, markedly elevated heart rate.
Severe toxicity: Seizures, dangerously low blood pressure, respiratory depression, cardiac arrhythmias, coma.

Not every overdose marches neatly through these stages. Some people jump to seizures relatively quickly, while others remain heavily sedated without ever becoming delirious. The variability has a lot to do with individual metabolism, body weight, and co-ingested substances.

The Heart Rhythm Risk

One of the less intuitive dangers of hydroxyzine overdose involves the heart’s electrical system. Hydroxyzine can delay the heart’s recovery between beats, a phenomenon measured on an ECG as QT prolongation. If the QT interval stretches too far, the heart becomes vulnerable to a specific type of dangerous arrhythmia called torsade de pointes, a chaotic rhythm that can degenerate into cardiac arrest.

This risk is not just theoretical. A review of global safety data spanning six decades found 59 reported cases of QT prolongation or torsade de pointes associated with hydroxyzine. Using prescription data available since 2007, the average reporting rate worked out to roughly 4 cases per million patient-years of use.³ That is a low rate at normal doses, but the risk climbs in overdose and when other QT-prolonging factors are present.

A published case report describes a patient who received a standard 50 mg dose of hydroxyzine for anxiety and developed torsade de pointes overnight. The arrhythmia did not respond to initial medication management and only resolved after the patient was sedated and intubated.⁴ That case involved a standard dose, not an overdose, which underscores why the cardiac risk has drawn so much regulatory attention. In overdose, the amount of drug hitting those cardiac ion channels is many times higher, and the danger rises proportionally.

Hydroxyzine Versus Diphenhydramine in Overdose

People often wonder how hydroxyzine stacks up against diphenhydramine (Benadryl) in overdose, since both are first-generation antihistamines with sedating and anticholinergic properties. The comparison is useful because diphenhydramine is available over the counter and has a much larger body of overdose data.

The same large cohort study that analyzed hydroxyzine poisonings also looked at over 102,000 diphenhydramine exposures. Across both datasets, hydroxyzine-poisoned patients had consistently lower rates of severe anticholinergic effects and were less likely to need intubation or benzodiazepines for seizure control. Deep coma, respiratory depression, seizures, and dangerous heart rhythms were all less frequent with hydroxyzine than with diphenhydramine.² The one exception was hyperthermia, which showed up at similar or slightly higher rates in hydroxyzine cases in one of the two datasets analyzed.

This does not mean hydroxyzine overdose is safe. It means that, on average, the anticholinergic toxicity profile tends to be somewhat milder than what you see with diphenhydramine at comparable levels of overdose. Hydroxyzine has less potency at muscarinic receptors than diphenhydramine does, which likely explains the difference.⁵ The flip side is that hydroxyzine carries the QT-prolongation risk that diphenhydramine does not share to the same degree, so the cardiac dangers may actually be greater with hydroxyzine in certain patients.

Children and Accidental Ingestion

Children are disproportionately vulnerable to hydroxyzine overdose for straightforward reasons: they weigh less, their organs are still developing, and they cannot articulate early warning symptoms. Even a handful of tablets can constitute a massive dose relative to body weight.

The first documented case of hydroxyzine toxicity from accidental ingestion in a child involved a 13-month-old who developed generalized seizures and rapid heart rate. Blood levels drawn about eight and a half hours after ingestion were extremely elevated at over 100 micrograms per milliliter. The child recovered fully within 72 hours with supportive care and seizure management using physostigmine.⁶ This case illustrates both the danger and the recoverability of even severe pediatric hydroxyzine toxicity when treatment is prompt.

For households with young children, the practical takeaway is that hydroxyzine should be stored like any other potentially dangerous medication: in a child-resistant container, out of reach and out of sight. Liquid formulations of hydroxyzine, which taste syrupy, are an especially high risk because children may drink a large amount quickly.

Drug Interactions That Make Overdose Worse

Hydroxyzine toxicity does not happen in isolation for many patients. The drug is frequently prescribed alongside other medications, and certain combinations can dramatically worsen the effects of even a modest excess dose.

The most concerning interactions fall into a few categories:

Other QT-prolonging drugs: Medications like certain antibiotics (azithromycin, fluoroquinolones), antipsychotics (haloperidol, quetiapine), and some antidepressants (citalopram) independently stretch the QT interval. Combine them with excessive hydroxyzine and the additive effect on the heart’s electrical system can push a patient into a dangerous arrhythmia.⁴
Central nervous system depressants: Alcohol, benzodiazepines, opioids, and other sedating drugs compound the brain-slowing effects of hydroxyzine. What might be moderate sedation from hydroxyzine alone can tip into respiratory depression and coma when these substances are on board.
Anticholinergic medications: Many common over-the-counter drugs (diphenhydramine, meclizine) and prescriptions (oxybutynin for overactive bladder, certain tricyclic antidepressants) block the same acetylcholine receptors that hydroxyzine does. The cumulative anticholinergic burden can produce severe toxicity even if no single drug is taken in excess.

Elderly patients are particularly vulnerable to these additive effects. Older adults tend to take more medications, metabolize drugs more slowly, and have less cardiac reserve to absorb the impact of QT prolongation. This is one reason regulatory agencies have pushed to limit hydroxyzine use in older populations.

Regulatory Warnings and Prescribing Restrictions

The cardiac risks prompted regulatory action in multiple countries. In April 2015, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) issued an advisory specifically about hydroxyzine’s risk of QT prolongation and torsade de pointes. A similar warning was issued to Canadian healthcare professionals in June 2016.⁷ Both communications framed these arrhythmias as a serious health concern because they can lead to sudden cardiac death.

The practical recommendations that came with these warnings included using the lowest effective dose, avoiding hydroxyzine altogether in elderly patients, and screening for other QT-prolonging medications before prescribing. In the European Union, the European Medicines Agency went further and recommended a maximum daily dose of 100 mg in adults (50 mg in the elderly) and advised against use in patients with known QT prolongation or existing cardiovascular disease. These restrictions did not pull hydroxyzine from the market, but they significantly narrowed the clinical situations where it should be a first-choice drug.

How Often Is Hydroxyzine Overdose Fatal?

Death from hydroxyzine overdose alone is uncommon. The large cohort analysis of U.S. poison data found mortality rates of 0.02% among cases reported to the National Poison Data System and 0.8% among cases in the more clinically detailed Toxicologic Investigators Consortium registry.² The difference between those two numbers largely reflects how each database captures cases: the poison data system includes calls about minor exposures that never reach a hospital, while the consortium registry is built from cases that clinicians specifically reported as significant poisonings.

When deaths do occur, forensic toxicology often reveals that hydroxyzine was not the only substance involved. Postmortem studies have found a wide range of hydroxyzine blood concentrations in deceased individuals, from levels near the therapeutic range all the way up to very high concentrations. In a study of postmortem cases, peripheral blood hydroxyzine concentrations ranged from 0.07 to 3.0 mg/L, with levels considered potentially therapeutic extending to at least 0.24 mg/L.⁸ Interpreting postmortem drug levels is complicated by the fact that hydroxyzine tends to redistribute after death, meaning levels measured in blood after death may not accurately reflect what was circulating when the person was alive.

A separate forensic study measuring both hydroxyzine and its active metabolite cetirizine in postmortem blood found hydroxyzine concentrations ranging from 6 to 622 ng/mL, with cetirizine at similar levels.⁹ The cetirizine angle matters because hydroxyzine is broken down by the liver into cetirizine (the same active ingredient in Zyrtec), and both compounds contribute to the overall drug burden in the body.

What Happens at the Emergency Department

There is no specific antidote for hydroxyzine. Treatment is supportive, meaning doctors manage the symptoms as they arise rather than neutralizing the drug directly. For mild cases, that might just be monitoring vital signs and waiting for the drug to clear the system. For more severe poisonings, the interventions escalate.

Seizures are typically controlled with benzodiazepines. Physostigmine, a drug that temporarily reverses anticholinergic effects, has been used in some cases, particularly the early pediatric case reports.⁶ However, physostigmine carries its own risks and is not used routinely in every hydroxyzine overdose. Cardiac monitoring is essential because of the QT prolongation risk, and any development of torsade de pointes requires immediate treatment, usually with intravenous magnesium and possibly electrical cardioversion.

Activated charcoal may be given if the patient presents within about an hour of ingestion and is alert enough to swallow safely. In cases where respiratory depression or severe ARDS develops, mechanical ventilation becomes necessary. The hospital stay for a significant hydroxyzine overdose can range from a day of observation for mild cases to a week or more in an intensive care unit for severe ones.

False Positives on Drug Screening

An often-overlooked consequence of hydroxyzine overdose is that it can interfere with standard urine drug screening. The immunoassay-based tests used in most emergency departments and workplaces are designed for speed, not specificity, and they are prone to cross-reactivity with structurally similar compounds.¹⁰

Hydroxyzine is a well-known cause of false-positive results for certain substance classes on these rapid screens. A person who has taken hydroxyzine, whether in overdose or at prescribed doses, may test positive on an initial screening for substances they never took. This can create real problems in clinical settings where treatment decisions are being made based on what substances someone supposedly ingested, and it can also have legal or employment consequences. Confirmatory testing using more precise methods will clear the false positive, but the initial result can cause confusion when time is critical.

Long-Term Effects After Recovery

Most people who survive a hydroxyzine overdose recover fully without lasting organ damage. The drug is eliminated from the body within a few days, and the anticholinergic effects resolve as it clears. In the documented pediatric case, full recovery occurred within 72 hours despite extremely high blood levels and seizure activity.⁶

The exceptions tend to involve secondary injury. If the overdose caused prolonged seizures, the brain may sustain damage from the seizure activity itself rather than from the drug directly. If torsade de pointes led to cardiac arrest with a period of poor blood flow to the brain, hypoxic injury is a possibility. And if severe respiratory failure or ARDS developed, lung recovery can take weeks to months. These complications, though, are not specific to hydroxyzine. They are the consequences of any overdose severe enough to cause sustained oxygen deprivation or prolonged seizures.

There is no established evidence linking a single hydroxyzine overdose to chronic cognitive impairment, liver damage, or kidney disease in patients who receive timely treatment. The more pressing long-term concern for many patients is the underlying reason the overdose occurred. In intentional overdoses, the most important intervention after medical stabilization is psychiatric evaluation and follow-up, because the risk of a repeat attempt is the greatest continuing danger.